A comparison of allocation strategies for optimising clinical trial designs under variance heterogeneity
From MaRDI portal
Publication:2674509
DOI10.1016/j.csda.2022.107559OpenAlexW4284670750MaRDI QIDQ2674509
David S. Robertson, Sofía S. Villar, Yuxuan Sun, Lida Mavrogonatou
Publication date: 14 September 2022
Published in: Computational Statistics and Data Analysis (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.csda.2022.107559
D-optimalityadaptive designsoptimal allocationvariance heterogeneityblocked designsoutcome-oriented allocation
Related Items (1)
Cites Work
- Unnamed Item
- Unnamed Item
- A Bayesian adaptive design for clinical trials in rare diseases
- Information-regret compromise in covariate-adaptive treatment allocation
- \(D\)-optimal designs for multi-response linear mixed models
- On recent advances in optimal allocation designs in clinical trials
- Adaptive designs for dose-finding based on efficacy-toxicity response
- Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpoint
- Bayes D-optimal and E-optimal block designs
- Response Surface Models with Random Block Effects
- Maximum Likelihood Approaches to Variance Component Estimation and to Related Problems
- Some practical advice on polynomial regression analysis from blocked response surface designs
- Sample size re‐estimation in clinical trials
- The Theory of Response‐Adaptive Randomization in Clinical Trials
This page was built for publication: A comparison of allocation strategies for optimising clinical trial designs under variance heterogeneity